£250K
The seed follow-on round was led by the Government Future Fund with matching contributions from Saker Capital and North East Innovation Fund.
Magnitude Biosciences
Magnitude Biosciences provides nematode worm testing services to accelerate preclinical drug discovery for biotech firms.
£250KTotal raised
Magnitude Biosciences is a contract research organisation based in County Durham that uses nematode worms to accelerate preclinical drug discovery. The company spun out from Durham University to provide specialised research services in ageing and neurodegenerative diseases.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Magnitude Biosciences's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
David Weinkove
Chief Executive
David brings academic and commercial experience, serving as a professor at Durham University, chief scientific officer at Magnitude Biosciences, and chair of the British Society for Research on Ageing.
LinkedIn
Sushmita Maitra
Sushmita brings extensive academic and research experience from roles at Durham University, the Gurdon Institute, and Magnitude Biosciences. She previously worked as an information scientist for the National Health Service.
LinkedInFT
Frederique Tholozan
Business Development Lead
Frederique brings business development and account management experience from roles at Magnitude Biosciences and REPROCELL.
LinkedIn
Christopher Saunter
Christopher serves as director at Magnitude Biosciences and brings academic experience from Durham University, where he held roles including associate professor and lecturer.
LinkedIn